Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INTERVIEW: Ding plans Betta chances for Conmana in China

This article was originally published in Scrip

Executive Summary

China is home to the world's largest aging population – approximately 200 million people over the age of 60. As such, chronic diseases such as diabetes and cancer have been the target for big pharma companies in the country. Among them is Betta Pharma (Betta), a private company founded in 2003 by Dr Lieming Ding, a former board-certified physician in the US, and his partners.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC025483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel